Accueil > Publications > COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer PatientsCOX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients1 mars 2018Anticancer Research DOI : 10.21873/anticanres.12375